Child mortality has been halved in the last 25 years. Building on this progress, new innovations in immunization are working ...

The team identified more than 7,200 babies eligible to have received nirsevimab during its inaugural 2023-24 RSV season. But ...

A new CHOP study found only one in three eligible patients took Beyfortus when the medication that protects against severe ...

WHO includes ArkBio' paediatric RSV drug, ziresovir in PADO-RSV priority list: Shanghai, China Thursday, July 17, 2025, 14:00 Hrs [IST] Shanghai Ark Biopharmaceutical Co., Ltd. (A ...

The Australian Medical Association fears WA is in the midst of one of the state's worst flu seasons as cases soar and ...

The RSV vaccination is currently recommended for all Australians aged 75 and over, or 60 and over for Aboriginal and Torres ...

Testing at India’s National Institute of Virology has confirmed a third recent Nipah virus case from India’s Kerla state, ...